OA17.05 Association Between Pre-Treatment Circulating Immune Biomarkers And Survival In Stage III NSCLC: A Translational Analysis From NRG-RTOG 0617
Year: 2023
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: M. Machtay, C. Hu, T.D. Schell, J.D. Bradley, G.H. Perdew, B. Lu, L. Beidler, F. Dong, R.C. Jordan, S. DeVries, M. Werner Wasik, Y.I. Garces, S. Narayan, C.G. Robinson, J.M. Rothman, A. Raben, V.S. Kavadi, E.M. Gore, T. Wu, F.-M. Kong
Institutions: Penn State Cancer Institute, American College of Radiology, NRG Oncology, Abramson Cancer Center, University of Pennsylvania, Pennsylvania State University, University of Missouri, University of California, San Francisco, University of California San Francisco Medical Center, Thomas Jefferson University Hospital, Mayo Clinic, Trinity Health, Washington University in St. Louis, UPMC Hillman Cancer Center, Medical College of Wisconsin, University of Hong Kong
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4388069379
